These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7078779)

  • 21. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE; Konrad D; Sawade H; Kühl I
    Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of patients with chronic hepatitis and cirrhosis of the liver].
    Kurdybaĭlo FV; Larina IG; Kulikova AN
    Vrach Delo; 1972 Jun; 6():19-23. PubMed ID: 5043595
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of bovine gallstone (Goou) and bear gall powder (Yutan) on chronic liver diseases: a preliminary report.
    Matsumoto N; Nakashima T; Kashima K
    Tokai J Exp Clin Med; 1995 May; 20(1):9-16. PubMed ID: 8869449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
    Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
    Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of patients with chronic liver diseases with a hepatotrophic preparation].
    Pagliaro L
    Minerva Med; 1971 Jul; 62(57):2840-3. PubMed ID: 4105219
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinico-experimental findings on the use of a new liver protective agent].
    Catalfamo G; Melotti G; Soffritti E
    Minerva Med; 1967 Apr; 58(34 Suppl):1605-12. PubMed ID: 4226047
    [No Abstract]   [Full Text] [Related]  

  • 29. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mesenchyma-suppressing therapy of chronic aggressive hepatitis].
    Gros H; Zwirner K; Herzog W
    Med Klin; 1972 Oct; 67(40):1277-82. PubMed ID: 4638147
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of chronic hepatitis and liver cirrhosis with 6-mercaptopurine and a methylhydrazine derivative].
    Göggel KH; Epperlein H
    Med Klin; 1965 Aug; 60(34):1362-8. PubMed ID: 5843139
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experiences with P-Carboxyphenylglycylaminoacetonitrile in refractory].
    Ota Y; Endo H
    Saishin Igaku; 1969 Jan; 24(1):185-7. PubMed ID: 5777190
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
    Loginow AS
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):19-23. PubMed ID: 4925665
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of active chronic hepatitis with 6-mercaptopurine.
    Sjöberg KH; Welin G
    Acta Hepatosplenol; 1967; 14(3):157-62. PubMed ID: 4172443
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum ornithyl-carbamyl-transferase activity in alcoholic hepatopathies].
    Mozzicato M; Villa D; Milani ET
    Minerva Med; 1980 Apr; 71(15):1077-80. PubMed ID: 7375018
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of acute and chronic liver diseases with combinations of vitamin B12 and anabolic hormones].
    Boeder KJ; Schmidt H; Khamsi A
    Med Welt; 1966 Apr; 14():730-4. PubMed ID: 5957304
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of pyrogenal on intracellular metabolism and phagocytic activity of leukocytes in patients with chronic liver diseases].
    Petrova TR; Ponomareva EP
    Klin Med (Mosk); 1975 Aug; 53(8):34-9. PubMed ID: 1186087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.